Advice
In the absence of a submission from the holder of the marketing authorisation
retapamulin (Altargo) is not recommended for use within NHSScotland for the short term treatment of the following superficial skin infections: Impetigo and infected small lacerations, abrasions, or sutured wounds.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice50KB (PDF)
Medicine details
- Medicine name:
- retapamulin (Altargo)
- SMC ID:
- 472/08
- Indication:
- for the short term treatment of the following superficial skin infections: Impetigo and infected small lacerations, abrasions, or sutured wounds.
- Pharmaceutical company
- GlaxoSmithKline UK Ltd
- BNF chapter
- Skin
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 07 April 2008